The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of ...
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go ...
The scope covers prescription drugs and drug-led, drug-device combination products where the Center for Drug Evaluation and ...
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, ...
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to ...
OpenAI acquired Orchestra Bio to pair AI agents that track drug development timelines with its Rosalind life sciences tools, ...
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ...
FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic ...
Bill Williams, AAPS, compares KinetiSol and spray drying for amorphous solid dispersions, covering 75% drug loading, pill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results